Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor
- 1 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (8), 4133-4154
- https://doi.org/10.1021/acs.jmedchem.9b02172
Abstract
Fluorescently labeled dibenzodiazepinone-type muscarinic acetylcholine receptor (MR) antagonists, including dimeric ligands, were prepared using red-emitting cyanine dyes. Probes containing a fluorophore with negative charge showed high M2R affinities (pKi (radioligand competition binding): 9.10–9.59). Binding studies at M1 and M3–M5 receptors indicated a M2R preference. Flow cytometric and high-content imaging saturation and competition binding (M1R, M2R, and M4R) confirmed occupation of the orthosteric site. Confocal microscopy revealed that fluorescence was located mainly at the cell membrane (CHO-hM2R cells). Results from dissociation and saturation binding experiments (M2R) in the presence of allosteric M2R modulators (dissociation: W84, LY2119620, and alcuronium; saturation binding: W84) were consistent with a competitive mode of action between the fluorescent probes and the allosteric ligands. Taken together, these lines of evidence indicate that these ligands are useful fluorescent molecular tools to label the M2R in imaging and binding studies and suggest that they have a dualsteric mode of action.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (GRK 1910)
- China Scholarship Council
This publication has 79 references indexed in Scilit:
- NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKsTrends in Pharmacological Sciences, 2018
- Assays with Detection of Fluorescence Anisotropy: Challenges and Possibilities for Characterizing Ligand Binding to GPCRsTrends in Pharmacological Sciences, 2018
- Dynamics of ligand binding to GPCR: Residence time of melanocortins and its modulationPharmacological Research, 2016
- Probing the pharmacology of G protein-coupled receptors with fluorescent ligandsNeuropharmacology, 2015
- Fluorescence‐ and bioluminescence‐based approaches to study GPCR ligand bindingBritish Journal of Pharmacology, 2015
- Fluorescent GPCR ligands as new tools in pharmacology-update, years 2008-early 2014.Current Medicinal Chemistry, 2014
- Fluorescent GPCR Ligands as New Tools in PharmacologyCurrent Medicinal Chemistry, 2008
- Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligandsEuropean Journal of Pharmacology, 2006
- BODIPY®‐conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypesBritish Journal of Pharmacology, 2005
- Fluorophore-tagged GPCR ligandsCurrent Opinion in Chemical Biology, 2005